Priority Testing

The World Health Organization recommends that people with HIV begin antiretroviral therapy when their CD4 count falls below 350 cells per microliter. This requires patients to have their CD4 counts tested, though developing countries may have limited numbers of labs and personnel to do the testing, says a new article in PLoS Medicine. Researchers led by the Wistar Institute's Luis Montaner tested a prediction-based classification method to determine when patients' CD4 levels fall. The model incorporates baseline CD4 levels, white blood cell count, and lymphocyte percent measurements. "Our results support the use of PBC modeling as a triage point at the laboratory, lessening the need for laboratory-based CD4+ T cell count testing; implementation of this tool could help optimize the use of laboratory resources, directing CD4 testing towards higher-risk patients," the researchers report.